These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30686514)

  • 21. 15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma.
    Mannelli M; Rapizzi E; Fucci R; Canu L; Ercolino T; Luconi M; Young WF
    Endocr Relat Cancer; 2015 Aug; 22(4):T83-90. PubMed ID: 26113605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste.
    Hall MJ; Forman AD; Obeid E
    JAMA Oncol; 2017 Dec; 3(12):1739-1740. PubMed ID: 28837713
    [No Abstract]   [Full Text] [Related]  

  • 23. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxysmal hypertension due to paraganglioma.
    PHILLIPS JR
    Am J Surg; 1947 Jan; 73(1):111-5. PubMed ID: 20279390
    [No Abstract]   [Full Text] [Related]  

  • 25. Pheochromocytoma and Paraganglioma: progress on all fronts.
    Gimenez-Roqueplo AP; Tischler AS
    Endocr Pathol; 2012 Mar; 23(1):1-3. PubMed ID: 22246920
    [No Abstract]   [Full Text] [Related]  

  • 26. Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma.
    Safford SD; Coleman RE; Gockerman JP; Moore J; Feldman JM; Leight GS; Tyler DS; Olson JA
    Surgery; 2003 Dec; 134(6):956-62; discussion 962-3. PubMed ID: 14668728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
    Lam AK
    Endocr Pathol; 2017 Sep; 28(3):213-227. PubMed ID: 28477311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Considerations on a case of a chromaffin tumor of the adrenal gland].
    SAPER J
    Neurol Neurochir Psychiatr Pol; 1961; 11():847-9. PubMed ID: 14497116
    [No Abstract]   [Full Text] [Related]  

  • 29. Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT.
    Fikri AS; Kroiss A; Ahmad AZ; Zanariah H; Lau WF; Uprimny C; Donnemiller E; Kendler D; Nordin AJ; Virgolini IJ
    Acta Radiol; 2014 Jun; 55(5):631-40. PubMed ID: 24037430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pheochromocytoma and paraganglioma: time and space are only part of the essence.
    Leung AA; Pasieka JL; Sadrzadeh H; Kline GA
    Eur J Endocrinol; 2021 Dec; 186(1):L3-L4. PubMed ID: 34709199
    [No Abstract]   [Full Text] [Related]  

  • 31. Validation and Evaluation of 5 Scoring Systems for Predicting Metastatic Risk in Pheochromocytoma and Paraganglioma.
    Li Q; Lan Z; Jiang Y; Wang R; Li Z; Jiang X
    Am J Surg Pathol; 2024 Jul; 48(7):855-865. PubMed ID: 38712603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of pheochromocytomas and paragangliomas.
    Opocher G; Schiavi F
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced coronary artery luminal area in pheochromocytoma and paraganglioma patients.
    Nazari MA; Abd-Elmoniem KZ; Jha A; Matta J; Talvacchio S; Charles K; Feeley J; Patel M; Feelders R; Pacak K; Gharib AM
    J Endocrinol Invest; 2023 Jul; 46(7):1483-1487. PubMed ID: 36538160
    [No Abstract]   [Full Text] [Related]  

  • 34. Multifocal pheochromocytoma-paraganglioma in a 29-year-old woman with cyanotic congenital heart disease.
    Wcislak SM; King WS; Waller BR; Goins N; Dickson PV
    Surgery; 2019 Jan; 165(1):228-231. PubMed ID: 30340856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CLINICAL AND BIOCHEMICAL DIAGNOSIS OF CHROMAFFIN TUMORS OF THE ADRENAL GLANDS].
    ALEKSANDROV D; VYSHNATSKA ALEKSANDROV V; IANUSHEVICH V; VOTSIAL B
    Vestn Akad Med Nauk SSSR; 1965; 20():46-51. PubMed ID: 14299976
    [No Abstract]   [Full Text] [Related]  

  • 36. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase.
    Gupta S; Zhang J; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):269-275. PubMed ID: 28752484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in the diagnosis of pheochromocytoma and paraganglioma syndrome.
    Zdrojowy-Wełna A; Bednarek-Tupikowska G
    Neuro Endocrinol Lett; 2014; 35(5):355-8. PubMed ID: 25275255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of malignant phaeochromocytoma of adrenal.
    BELKIN A; MACQUEEN DG; DUFFIN JD
    Treat Serv Bull; 1953 Sep; 8(8):496-500. PubMed ID: 13090309
    [No Abstract]   [Full Text] [Related]  

  • 39. Laparoscopic resection of periadrenal paraganglioma in a patient with multiple endocrine neoplasia type 2A.
    Nomura T; Takahashi M; Ando T; Sato F; Fujii S; Mimata H
    Surg Laparosc Endosc Percutan Tech; 2011 Feb; 21(1):e31-3. PubMed ID: 21304370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation.
    Makis W; McCann K; McEwan AJ; Sawyer MB
    Clin Nucl Med; 2016 Mar; 41(3):204-6. PubMed ID: 26359568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.